BriaCell Share Price

BriaCell Share Price

NASDAQ: BCTXZ | Micro Cap | Healthcare
$0.11
-$0.00 (-0.64%) Last updated on 17 Nov, 2026 | 23:35 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

BriaCell Stock Performance

Open
$0.13
Prev. Close
$0.11
Circuit Range
N/A
Day Range
$0.11 - $0.13
Year Range
$0.08 - $0.42
Volume
2,600
Average Traded
$0.13

BriaCell Share Price Today

As of 22 November 2026, BriaCell Therapeutics Corp. Warrant expiring 2030's share price is $0.11. The stock opened at $0.13, compared to its previous close of $0.11. During today's trading session, BriaCell Therapeutics Corp. Warrant expiring 2030's share price traded between $0.11 and $0.13, with an average price of $0.12. Over the past 52 weeks, the stock has recorded a high of $0.42 and a low of $0.08. In terms of performance, BriaCell Therapeutics Corp. Warrant expiring 2030's share price has risen by 20.00% over the last six months and is down 74.10% on a year-on-year basis.

BriaCell Share Price Chart

Line chart of the BriaCell price trend over the selected period. The price fell overall, ranging from 0.11 to 0.13, ending at 0.11.
$0.11$0.13
L
Show Current Price
H

BriaCell Stock Fundamentals & Key Indicators

Market Cap
$45696.31
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
-212.82%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-50.24%

BriaCell Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.20-$7.22-$7.16-$12.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A11.95%0.83%-72.07%

BriaCell Annual Profit & Loss

All figures in USD

Particulars20252026
Revenue$0.00$0.00
Net Profit-$26.31-$34.90
Net Profit MarginN/AN/A
Income ChangeN/A-32.65%

BriaCell Balance Sheet

All figures in USD Million

Particulars20262025
Non Current Assets1.531.72
Current Assets22.0419.93
Total Assets23.5821.65
Non Current Liabilities0.040.34
Current Liabilities7.983.98
Total Liabilities8.024.32
Shareholders' Equity15.5617.33

BriaCell Cash Flow

Annually

All figures in USD Million

Particulars20262025
Operating-28.65-28.17
Investing-3.81-7.65
Financing31.8145.45

About BriaCell

BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.

BriaCell Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.14
$0.11
-61.43%
Oct 2026
$0.28
$0.28
+47.37%
Sep 2026
$0.19
$0.19
+126.19%
Aug 2026
$0.08
$0.08
-6.67%
Jul 2026
$0.10
$0.09
+12.50%
Jun 2026
$0.08
$0.08
-11.11%
Apr 2026
$0.15
$0.09
-21.05%
Mar 2026
$0.16
$0.11
-25.49%
Feb 2026
$0.14
$0.15
-10.00%
Jan 2026
$0.28
$0.17
-37.04%
Dec 2025
$0.42
$0.27
-16.41%
Nov 2025
$0.36
$0.32
-22.54%

BriaCell Share Price FAQs